These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21067018)

  • 1. Clinical efficacy of the various drugs used in the treatment of gonorrhoeae.
    Shams-ur-Rehman ; Khan A; Amanullah ; Akhter K
    J Ayub Med Coll Abbottabad; 2009; 21(4):28-30. PubMed ID: 21067018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
    Kubanova A; Frigo N; Kubanov A; Sidorenko S; Priputnevich T; Vachnina T; Al-Khafaji N; Polevshikova S; Solomka V; Domeika M; Unemo M
    Sex Transm Infect; 2008 Aug; 84(4):285-9. PubMed ID: 18256105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
    Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N
    Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].
    García S; Casco R; Perazzi B; De Mier C; Vay C; Famiglietti A
    Medicina (B Aires); 2008; 68(5):358-62. PubMed ID: 18977704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.
    Bala M; Ray K; Salhan S
    Sex Transm Infect; 2005 Apr; 81(2):186-7. PubMed ID: 15800110
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
    Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
    Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
    Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
    Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
    Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
    Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
    Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
    Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
    Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spectinomycin resistant gonococcal infections in West Germany. Detection in 7 patients and occurrence of post-gonorrheal epididymitis caused by the spectinomycin-resistant PPNG strain].
    Orfanos CE; Adler M; Hörnle R; Stadler R; Wagner J
    Hautarzt; 1989 Nov; 40(11):713-7. PubMed ID: 2532631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
    Berglund T; Colucci B; Lund B; Qvarnström I; Sandström E
    Lakartidningen; 2004 Jul; 101(28-29):2332-5. PubMed ID: 15291311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.
    Muratani T; Inatomi H; Ando Y; Kawai S; Akasaka S; Matsumoto T
    Int J Urol; 2008 Sep; 15(9):837-42. PubMed ID: 18665871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
    Lewis DA; Scott L; Slabbert M; Mhlongo S; van Zijl A; Sello M; du Plessis N; Radebe F; Wasserman E
    Sex Transm Infect; 2008 Oct; 84(5):352-5. PubMed ID: 18596070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
    Portilla I; Lutz B; Montalvo M; Mogabgab WJ
    Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose ampicillin/sulbactam versus ceftriaxone as treatment for uncomplicated gonorrhoea in a Ugandan STD clinic population with a high prevalence of PPNG infection.
    Hellmann NS; Nsubuga PS; Baingana-Baingi DJ; Desmond-Hellmann SD; Mbidde EK; Granowitz CB; Sande MA
    J Trop Med Hyg; 1995 Apr; 98(2):95-100. PubMed ID: 7714943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.
    Bai ZG; Bao XJ; Cheng WD; Yang KH; Li YP
    Int J STD AIDS; 2012 Feb; 23(2):126-32. PubMed ID: 22422688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim guidelines for the treatment of uncomplicated gonococcal infection. The Laboratory Center for Disease Control.
    Can Dis Wkly Rep; 1991 Dec; 17(51):281-2. PubMed ID: 1843662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.